Cancer News
OncoLink Cancer News - HealthDay


Proteins Expressed in Liver Cancer May Indicate Prognosis

-- Jeff Muise

Friday, October 30, 2009

FRIDAY, Oct. 30 (HealthDay News) -- The expression of certain epithelial-mesenchymal transition (EMT) protein regulators in primary hepatocellular carcinoma (HCC) are correlated with disease invasiveness, metastasis and a poor prognosis, according to a study in the November issue of Hepatology.

Muh-Hwa Yang, M.D., of the National Yang-Ming University in Taipei, Taiwan, and colleagues compared 123 samples of HCC liver tissue with adjacent non-cancer tissue from patients who had liver surgery from 1990 to 2002. The researchers examined the tissues for expression of markers of EMT, which is thought to drive cancer invasiveness and metastasis.

The researchers found decreased E-cadherin and nonmembranous β-catenin expression, two indications of EMT, in 60.2 and 51.5 percent of HCC tissue samples, respectively. They also found overexpression of the major EMT protein regulators Snail, Twist, or Slug in 56.9, 43.1, and 51.4 percent of HCC tissue samples, respectively. Co-expression of Snail and Twist expression correlated with decreased E-cadherin and nonmembranous β-catenin and produced the worst prognosis for HCC patients, but the correlation was not found for overexpression of Slug.

"These results elaborate on the major mechanisms involved in HCC metastasis and provide essential information for prediction of prognosis and identification of new treatment targets for future HCC management," the authors write.

Abstract
Full Text (subscription or payment may be required)

Specialties Cardiology
Diabetes & Endocrinology
Internal Medicine
Family Practice

Copyright © 2009 ScoutNews, LLC. All rights reserved.


I Wish You Knew

Pain management in cancer care - are patients getting what they need?

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More